# ctDNA for Risk Stratification in Melanoma

> **NCT07531121** · — · ACTIVE_NOT_RECRUITING · sponsor: **Herlev and Gentofte Hospital** · enrollment: 296 (actual)

## Conditions studied

- Melanoma (Skin Cancer)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07531121
- **Lead sponsor:** Herlev and Gentofte Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-10
- **Primary completion:** 2025-05-20
- **Final completion:** 2026-05-03
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07531121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07531121, "ctDNA for Risk Stratification in Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07531121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*